The efficacy and safety of biosimilar infliximab CT-P13 in IBD: a prospective, nationwide, observational cohort (Biosimilar infliximab in IBD) First published 21/03/2015 Last updated 21/03/2015 EU PAS number:EUPAS9053 Study Ongoing